| Lancet
| [0013]
|
| Clin. Exp. Pharmacol. Physiol
| [0013]
|
| Antisense Nucleic Acid Drug Dev
| [0013]
|
| Antisense Nucleic Acid Drug Dev
| [0013]
|
| J. Pharm. Sci
| [0013]
|
| Mol. Ther
| [0013]
|
| Virology
| [0013]
|
| Viruses
| [0013]
[0013]
|
| Antimicroh. Agents Chemother
| [0013]
|
| Nucleic Acids Research
| [0021]
|
| Angew. Chem. Internal. Ed
| [0021]
|
| Tetrahedron Lett.
| [0021]
|
| Tetrahedron Letters
| [0021]
|
| Organic Process Research & Development
| [0021]
|
| J. Am. Chem. Soc
| [0021]
|
| J. Am. Chem. Soc.
| [0021]
|
| Bioorg. Chem
| [0021]
|
| J. C. S. Perkin I
| [0021]
|
| J. Chrom. Sci
| [0021]
|
| Israel J. Chem
| [0021]
|
| Peptides
| [0021]
|
| Tetrahedron lett.
| [0021]
|
| Proc. Natl. Acad. Sci. USA
| [0021]
|
| Proc. Natl. Acad. Sci. USA
| [0021]
|
| Chem. Rev
| [0034]
|
| Antisense and Nucleic Acid Drug Development
| [0127]
|
| Stereo-chemistry of Carbon Compounds
| [0128]
|
| Advanced Organic Chemistry
| [0128]
|
| Antisense & Nucleic Acid Drug Dev
| [0130]
|